IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/kingston-financial-group-ltd" target="_blank" data-smartkarma-citation="entities:3566:1" rel="noopener">Kingston Financial (1031 HK)</a> entered a trading halt pending an announcement under the Hong Kong Code on Takeovers and Mergers on 14 October. The shares are at all-time lows. </li>
<li>It is likely that Pollyanna Chu Yuet Wah (CEO and co-founder), the largest shareholder representing 75.61% of ordinary shares (80.09% of diluted shares), is seeking to privatise Kingston.</li>
<li>As privatisation through a Bermuda scheme involves the headcount test, a decent premium is required - an offer at the 1-year average price of HK$0.33 implies a 63% premium.</li>
</ul>



Kingston Financial (1031 HK) entered a trading halt pending an announcement under the Hong Kong Code on Takeovers and Mergers on 14 October. The shares are at all-time lows. 
It is likely that Pollyanna Chu Yuet Wah (CEO and co-founder), the largest shareholder representing 75.61% of ordinary shares (80.09% of diluted shares), is seeking to privatise Kingston.
As privatisation through a Bermuda scheme involves the headcount test, a decent premium is required - an offer at the 1-year average price of HK$0.33 implies a 63% premium.


Kingston’s All-Time Lows to Draw an Offer from Mrs Chu?

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyse the changes of A-H premium on 142 stocks over the last week. The average A-H premium was 113.9% as of Sep 16th.</li>
<li>The average A-H premium changed by -4.6ppt weeok on week, led by financials,  communication services, health care, and offset by consumer staples, consumer discretionary, utilities.</li>
<li>We highlight weekly changes in A-H premium for Angang, CIMC, Zoomlion, Huatai securities, Tianqi Lithium, China Telecom.</li>
</ul>


We analyse the changes of A-H premium on 142 stocks over the last week. The average A-H premium was 113.9% as of Sep 16th.
The average A-H premium changed by -4.6ppt weeok on week, led by financials,  communication services, health care, and offset by consumer staples, consumer discretionary, utilities.
We highlight weekly changes in A-H premium for Angang, CIMC, Zoomlion, Huatai securities, Tianqi Lithium, China Telecom.


A-H Premium Weekly (Sep 16th): Angang, CIMC, Zoomlion, Huatai, Tianqi Lithium

<ul>
<li>We analyse the changes of A-H premium on 143 stocks over the last week. The average A-H premium was 116.6% as of Sep 2nd.</li>
<li>The average A-H premium changed by 4.9ppt, led by Communication Services, Financials, Health Care and offset by Energy, Consumer Staples.</li>
<li>We highlight weekly changes in A-H premium for Remegen, Huaxin, Huatai, Tianqi Lithium, Shandong Gold.</li>
</ul>


We analyse the changes of A-H premium on 143 stocks over the last week. The average A-H premium was 116.6% as of Sep 2nd.
The average A-H premium changed by 4.9ppt, led by Communication Services, Financials, Health Care and offset by Energy, Consumer Staples.
We highlight weekly changes in A-H premium for Remegen, Huaxin, Huatai, Tianqi Lithium, Shandong Gold.


A-H Premium Weekly (Sep 2nd): Remegen, Huaxin, Huatai, Tianqi Lithium

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/magic-empire-global" target="_blank" data-smartkarma-citation="entities:36219:1" rel="noopener">Magic Empire Global (MEGL US)</a> shares are currently up 45x since its listing at US$4.00 per share on 5 August. Its market cap currently stands at US$3.6 billion.</li>
<li>Just like <a href="https://www.smartkarma.com/entities/amtd-digital" target="_blank" data-smartkarma-citation="entities:36214:1" rel="noopener">AMTD Digital (HKD US)</a>, it is hard to pinpoint the real reason for MEGL’s share price surge. MEGL’s financials are uninspiring and cannot justify the share price ramp.</li>
<li>MEGL has no unique competitive advantage which could justify it's current large premium multiple compared to larger and better-established peers.    </li>
</ul>



Magic Empire Global (MEGL US) shares are currently up 45x since its listing at US$4.00 per share on 5 August. Its market cap currently stands at US$3.6 billion.
Just like AMTD Digital (HKD US), it is hard to pinpoint the real reason for MEGL’s share price surge. MEGL’s financials are uninspiring and cannot justify the share price ramp.
MEGL has no unique competitive advantage which could justify it's current large premium multiple compared to larger and better-established peers.    


Magic Empire Global: More Trick than Treat

<ul>
<li>We analyse the changes of A/H premium on 140 stocks over the last week. </li>
<li>Week on week A-H premium decline was mainly due to the information technology, utilities and health care sector and offset by the increase of premium in consumer discretionary.</li>
<li>We highlight A-H premium changes in Shandong Xinhua, Shenhua, Huaxin Cement, Ganfeng Lithium, Tsingtao Brewery, and Baiyunshan.</li>
</ul>


We analyse the changes of A/H premium on 140 stocks over the last week. 
Week on week A-H premium decline was mainly due to the information technology, utilities and health care sector and offset by the increase of premium in consumer discretionary.
We highlight A-H premium changes in Shandong Xinhua, Shenhua, Huaxin Cement, Ganfeng Lithium, Tsingtao Brewery, and Baiyunshan.


A-H Premium Weekly: Shandong Xinhua, Shenhua, Ganfeng Lithium

China

Huatai Securities Co., Ltd. operates securities businesses. The Company provides securities brokerage, securities underwriting, asset management, investment banking, and online exchange services. Huatai Securities mainly conducts businesses domestically.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Huatai Securities Co Ltd (HTSC LI)

Kingston’s All-Time Lows to Draw an Offer from Mrs Chu?

Mrs Chu (CEO and co-founder) is likely seeking to privatise Kingston. A decent premium is required as privatisation through a Bermuda scheme (most...

Arun George

A-H Premium Weekly (Sep 16th): Angang, CIMC, Zoomlion, Huatai, Tianqi Lithium

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Angang, CIMC, Zoomlion, Huatai securities, Tianqi Lithium,...

Ke Yan, CFA, FRM

A-H Premium Weekly (Sep 2nd): Remegen, Huaxin, Huatai, Tianqi Lithium

We analyzed A-H premium last week and highlight weekly changes in A-H premium for Remegen, Huaxin, Huatai, Tianqi Lithium, Shandong Gold.

Ke Yan, CFA, FRM

Magic Empire Global: More Trick than Treat

It is hard to pinpoint the real reason for MEGL’s share price surge. While it is difficult to predict when the share price will reflect...

Arun George

A-H Premium Weekly: Shandong Xinhua, Shenhua, Ganfeng Lithium

We highlight weekly A-H premium changes in Shandong Xinhua, Shenhua, Huaxin Cement, Ganfeng Lithium, Tsingtao Brewery, and Baiyunshan.

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)